View Older Stories View More Recent Stories
-
PCI Pharma Services Enters Next Phase of Growth With Strategic Investment from Bain Capital, Kohlberg, and Mubadala
-
Citi Quant Crowding Analysis: 'It is interesting to note SHW is now ranked 15th on our list of crowded longs'
-
Citi: 'Even with the pending rate-cut expected in 2H, it remains to be seen how quickly this could translate to improved volumes for SHW'
-
Citi on Amylyx Pharmaceuticals inc. (AMLX): 'we think avexitide is well positioned to demonstrate success'
-
Citi on Kenvue Inc (KVUE): 'We expect a positive reaction today to the news'
-
Citi: 'We expect July benchmark kraftliner prices out Friday to come in flat at $945/ton'
-
Ferrellgas hires Safran Advisors LLC Managing Partner, Andrew Safran
-
Citi on AppLovin Corp (APP) Ahead of Earnings: 'remains our top pick'
-
NIQ Global Intelligence (NIQ) Launches 50M Share IPO
-
NIQ Announces Launch of Initial Public Offering
-
Form 424B2 CITIGROUP INC
-
Form 424B2 CITIGROUP INC
-
Waters to merge with BD's biosciences unit in $17.5 billion deal
-
Waters and BD's Biosciences & Diagnostic Solutions Business to Combine, Creating a Life Science and Diagnostics Leader Focused on Regulated, High-Volume Testing
-
Analysis-US bank M&A hopes revive under Trump regulators
-
Citi Reiterates Buy Rating on Arista Networks (ANET), Opens 90d Upside Cat Call
-
Citi Reiterates Buy Rating on Autodesk (ADSK)
-
Super Micro Computer (SMCI) PT Raised to $52 at Citi
-
CDW Corporation (CDW) PT Raised to $200 at Citi
-
Levi Strauss & Co. (LEVI) PT Raised to $22 at Citi
-
Citi Reiterates Buy Rating on DraftKings Inc. (DKNG)
-
Citi Reiterates Buy Rating on Hess Midstream Partners LP (HESM)
-
Vital Energy (vtle) PT Raised to $20 at Citi
-
Starbucks (SBUX) PT Raised to $100 at Citi
-
Citi Reiterates Buy Rating on BridgeBio Pharma (BBIO)
-
Citi: 'Reiterate MCHP As Our Top Pick with TXN #2 Given Highest EPS Growth'
-
Citizens JMP Reiterates Market Outperform Rating on Meta Platforms Inc. (META)
-
Citi Starts Caris Life Sciences Inc (CAI) at Buy
-
Citizens JMP Reiterates Market Outperform Rating on Snap Inc (SNAP)
-
Citizens JMP Reiterates Market Outperform Rating on Roku Inc. (ROKU)
-
Citizens JMP Upgrades Rhythm Pharmaceuticals (RYTM) to Market Outperform
-
Citizens JMP Reiterates Market Outperform Rating on Sprinklr Inc (CXM)
-
Citigroup (C) July 87 priced into quarter results
-
Citizens JMP Reiterates Market Outperform Rating on Asana (ASAN)
-
Citizens JMP Reiterates Market Outperform Rating on Abivax (ABVX)
-
Citizens JMP Downgrades Goldman Sachs (GS) to Market Perform
-
Citizens JMP Downgrades Evercore Partners (EVR) to Market Perform
-
Citizens JMP Downgrades KKR (KKR) to Market Perform
-
Citizens JMP Downgrades SoFi Technologies (SOFI) to Market Perform
-
Citizens JMP Downgrades Core Scientific Inc. (CORZ) to Market Perform
-
Citizens JMP Starts Hinge Health Inc (HNGE) at Market Outperform
-
Citizens JMP Starts SGHC Limited (SGHC) at Market Outperform
-
Citizens JMP Starts Slide Insurance Holdings (SLDE) at Market Outperform
-
Citi favors these life science tools stocks ahead of earnings
-
New Trump tariff threats rekindle investor concerns about trade and timelines
-
Form 424B2 CITIGROUP INC
-
Form 424B2 CITIGROUP INC
-
Form 424B2 CITIGROUP INC
-
Form 424B2 CITIGROUP INC
-
Form 424B2 CITIGROUP INC
